文献速递脑血管病外科神经重症

现代未破裂颅内动脉瘤显微外科治疗后的死亡率

Mortality After Microsurgical Treatment of Unruptured Intracranial Aneurysms in the Modern Era.
PubMed 文献 · World Neurosurg · 2023-09-26

该研究回顾性分析了2014年1月1日至2020年12月31日在一家大型四级中心接受择期显微外科治疗的488例未破裂颅内动脉瘤患者的死亡情况,出院时死亡1例(0.2%),1年随访时共8例死亡(1.6%)。多因素分析显示仅非囊状动脉瘤和较高的美国麻醉医师协会分级是死亡预测因素。

要点

  • 488例未破裂颅内动脉瘤显微外科治疗患者中,1年随访死亡率为1.6%(8例)。
  • 出院时死亡1例(0.2%),为非囊状椎基底动脉瘤患者。
  • 多因素分析显示非囊状动脉瘤和较高美国麻醉医师协会分级是死亡预测因素。

核心结论

  • 近期显微外科治疗未破裂颅内动脉瘤的死亡率较低。
  • 非囊状动脉瘤和较高的美国麻醉医师协会分级似乎是死亡的预测因素。

研究设计与样本

  • 回顾性分析2014年1月1日至2020年12月31日在一家大型四级中心接受择期显微外科治疗的未破裂颅内动脉瘤患者的病历资料。
  • 共纳入488例患者,平均(标准差)年龄58(12)岁,其中61例(12.5%)有既往蛛网膜下腔出血史。
  • 主要结局为出院时和1年随访时的死亡率,采用单因素至多因素逐步分析,纳入标准为P < 0.20。

主要发现

  • 1例(0.2%)患者在住院期间死亡,该患者为 Dolichoectatic 椎基底动脉瘤。
  • 1年随访时共8例(1.6%)死亡,除住院期间死亡的1例外,另7例死亡原因分别为:创伤1例、心肌梗死2例、脑血管意外2例、肺栓塞1例、硬膜下血肿合并脓肿1例。
  • 单因素分析显示,随访时死亡的显著危险因素包括糖尿病、术前使用抗凝药或抗血小板药、动脉瘤钙化、非囊状动脉瘤和较高的美国麻醉医师协会分级(均P < 0.03)。
  • 多因素logistic回归分析显示,仅非囊状动脉瘤和较高的美国麻醉医师协会分级是死亡的预测因素。

关键数值与推荐

  • 1年随访死亡率:8/488(1.6%)。
  • 出院时死亡率:1/488(0.2%)。
  • 单因素分析中与随访死亡率显著相关的因素:糖尿病、术前抗凝药或抗血小板药使用、动脉瘤钙化、非囊状动脉瘤、较高的美国麻醉医师协会分级(均P < 0.03)。
  • 多因素logistic回归分析中死亡的预测因素:非囊状动脉瘤和较高的美国麻醉医师协会分级。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The incidence of mortality after treatment of unruptured intracranial aneurysms (UIAs) has been described historically. However, many advances in microsurgical treatment have since emerged, and most available data are outdated. We analyzed the incidence of mortality after microsurgical treatment of patients with UIAs treated in the past decade. METHODS: The medical records of all patients with UIAs who underwent elective treatment at our large quaternary center from January 1, 2014, to December 31, 2020, were reviewed retrospectively. We analyzed mortality at discharge and 1-year follow-up as the primary outcome using univariate to multivariable progression with P < 0.20 inclusion. RESULTS: During the 7-year study period, 488 patients (mean [SD] age = 58 [12] years) had UIAs treated microsurgically. Of these patients, 61 (12.5%) had a prior subarachnoid hemorrhage. One patient (0.2%) with a dolichoectatic vertebrobasilar aneurysm died while hospitalized, and 7 other patients (8 total; 1.6%) were determined to have died at 1-year follow-up (1 trauma, 2 myocardial infarction, 2 cerebrovascular accident, 1 pulmonary embolism, and 1 subdural hematoma complicated by abscess). On univariate analysis, significant risk factors for mortality at follow-up included diabetes mellitus, preoperative anticoagulant or antiplatelet use, aneurysm calcification, nonsaccular aneurysm, and higher American Society of Anesthesiologists grades (all P < 0.03). On multivariable logistic regression analysis, only nonsaccular aneurysms and higher American Society of Anesthesiologists grades were predictors of mortality. CONCLUSIONS: A low mortality rate is associated with recent microsurgical treatment of UIAs. However, nonsaccular aneurysms and higher American Society of Anesthesiologists grades appear to be predictors of mortality.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Catapano JS, Koester SW, Rhodenhiser EG, et al. Mortality After Microsurgical Treatment of Unruptured Intracranial Aneurysms in the Modern Era. World Neurosurg. 2023. PMID: 37769845. doi:10.1016/j.wneu.2023.09.081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。